POSC113 Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in the Treatment of HER2-Positive Breast Cancer (HER2+ BC) Patients in Italy: A Budget Impact Analysis
Bellone, M ; Pradelli, L ; Sanfilippo, A ; Caputo, A ; Manevy, F ; Zerilli, A
Value in health, 2022-01, Vol.25 (1), p.S109-S109 [Periódico revisado por pares]Elsevier Inc
Texto completo disponível
Anterior
Página Inicial
RSS
Feed
Políticas
Fale Conosco-
Realização:
Logos de Redes Sociais: 